Sumifun 4% Lidocaine Pain Relief Patches 30 Count(Pack of 1)
关节和肌肉疼痛缓解药物 - 产品分析报告
  • Benchmark ASIN
    B0CDVW1LPW
  • Marketplace
    US
  • Category ID
    15219081
  • Analyzed Products
  • Keyword
    lidocaine pain relief patches, maximum strength lidocaine patches, 4% lidocaine back patches
  • Price Range
    $19.00–$99.00
  • Minimum Net Profit Margin
    10.00%
  • MOQ
    300
  • Est. Purchasing Cost
    Owner only
  • Data Date
    2026-09-09
  • Your Budget (for new listing) (CNY)
    ¥100,000.00
Profitability Difficulty
Low
High Risk Due to Price Competition
Newly Released Counts (All Brands)
48
New Brand (36)
Old Brand (12)
Success rate (all brands)
0.00%
New Brand (0.00%)
Old Brand (0.00%)
Most products net profit margin range
Owner only

Report summary from Keble AI Agent: Listing

Visible to the report owner only

Recommended Products Features Direction
B0BPDQP7JR
Why do customers choose it?
  • 浅蓝色医疗风包装,相比多数竞品的深蓝黄盒装更柔和醒目
  • 柔性贴片袋装展示而非传统纸盒装,视觉上更像便携护理用品
  • 40贴大包装,单片成本感知更强
  • 更关注居家长期备货、偏好柔和医疗风外观的疼痛贴消费者
  • Sales
    Avg. price: $26.99|Latest price: $26.99|Approx. recent monthly revenue: - (- pcs)|Visible to the report owner only
    B0GWD7DMXC
    Why do customers choose it?
  • 附带辅助贴固定结构,强调增强贴合与稳固性
  • 需要在活动时保持贴片更稳固、不易移位的人群
  • Sales
    Avg. price: $29.46|Latest price: $29.99|Approx. recent monthly revenue: - (- pcs)|Visible to the report owner only

    These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.

    New Brands
    VS
    Old Brands
    17 new brands9 old brands
    17 brands have new listings2 brands have new listings
    36 new listings12 new listings
    0 succeeded
    0 succeeded
    36 failed
    12 failed

    Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.

    New Brands
    ...
    Old Brands
    ...

      How much did others invest?

      Collapse
    • #Budget Requirement

      Visible to the report owner only

      Early sourcing + logistics + marketing budget (USD)
      N/A
      Explains the budget

      With all these investments, who has profitable new releases

      How many new listings are released by old brands?
      25.00%
      New listing success rate (old brands):
      0.00%
      New listing success rate (new brands):
      0.00%
      Alternatives
      1. TENS电脉冲止痛贴/便携式理疗仪:对背痛、肌肉酸痛、坐骨神经痛等人群,这是比4%利多卡因贴更有策略威胁的替代方案。原因是可重复使用、长期单次使用成本更低、无需反复购买耗材,且在亚马逊和线下药房都很容易获得。用户若追求‘非药物止痛’或担心皮肤刺激,往往会转向这类产品。
      2. 非处方外用止痛贴/膏中的其他活性成分方案:如薄荷醇、樟脑、水杨酸甲酯、辣椒素等止痛贴、止痛凝胶、止痛霜。这类产品通常价格更低、品牌更多、线下可得性强,且很多消费者并不执着于‘lidocaine’成分,而是只想获得局部镇痛/清凉热感缓解,因此会直接在同类外用镇痛品中替代购买。
      3. 止痛凝胶/乳膏/滚珠类外用产品:相较利多卡因贴,这类剂型对‘不想贴一整片、希望灵活涂抹肩颈/关节/小面积疼痛部位’的用户更方便,也常常更便宜。对于腰背痛以外、面积不规则部位,凝胶和乳膏在使用便捷性上可能优于贴片,属于高相关替代。
      4. 热疗类产品:如一次性发热贴、热敷贴、可重复加热热敷包。对于很多背部酸痛、劳损、经期腰痛、办公室久坐人群,用户真正购买的是‘缓解疼痛’而非‘局麻成分’,因此热疗产品会分流需求。它们通常更便宜、认知门槛更低,也更容易在线下便利店、药房购买。
      5. 背部支撑/护腰/姿势矫正类产品:对于反复腰背痛用户,一部分消费者会优先购买‘支撑+固定+减压’方案,而不是短效止痛贴。尤其在工作、运动、久坐场景中,护腰产品被视为更偏长期解决方案,可能替代止痛贴预算。
      6. 口服非处方止痛药:如对乙酰氨基酚、布洛芬、萘普生等。虽然不属于同剂型,但在消费者决策里是非常现实的替代:更便宜、更普及、购买习惯成熟、见效预期明确。很多用户在面对局部疼痛时,会直接选择口服止痛药而非外用利多卡因贴。
      7. 电商平台上的更高浓度或‘更专业感’的疼痛贴片方案:如OTC 4%利多卡因与处方5%利多卡因贴之间的认知替代,以及含更多功能卖点(大尺寸、强粘性、切割线、冷感/热感复合)的贴片。即使用户仍购买‘止痛贴’,也可能不买标准4% back patch,而转向 perceived stronger 的方案。
      8. 按摩枪、筋膜球、背部按摩器等居家缓解工具:对运动恢复、办公室肩颈腰背疲劳人群,这些产品常被视为比一次性止痛贴更值得投入的替代方案。虽然客单价更高,但可长期使用,且在社媒内容带动下具有较强替代性。

      Alternative solutions may pose a risk to your investment in certain markets.

    • #Brands Investment Analysis

      Visible to the report owner only

      koeyre
      Most investment in new productsNew products with Highest revenueLeast investment in new products
      4% Lidocaine Patches, Maximum OTC Strength Relief, Fast Acting, 30 Count
      Recent Monthly Revenue (USD):-(-)
      B0H9LV4FVQ (5/5 (4 Reviews))Brand is a new entry in this market
      New ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 300 MOQ
      4% Lidocaine Pain Relief Patches ,Maximum Strength,Targeted Relief-30 Count
      Recent Monthly Revenue (USD):-(-)
      B0H6HT6JXH (5/5 (4 Reviews))Brand is a new entry in this market
      New ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 300 MOQ
      4% Lidocaine Pain Relief Patches, Fast Acting,Maximum OTC Strength,30 Count
      Recent Monthly Revenue (USD):-(-)
      B0HC9YHMPC (3.4/5 (15 Reviews))Brand is a new entry in this market
      New ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 300 MOQ
      Curist
      Old brand with the most profitable new products
      Curist Lidocaine Patches 4% Topical Pain Relief (40 Patches) Super Stick
      Recent Monthly Revenue (USD):-(-)
      B0BPDQP7JR (3.8/5 (203 Reviews))Brand is an old entry in this market
      Old ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 300 MOQ
    • #Differentiations

      Visible to the report owner only

      Unique productsCommon products
      Curist Lidocaine Patches 4% Topical Pain Relief (40 Patches) Super Stick
      Differentiation:
      Visible to the report owner only
      B0BPDQP7JR (3.8/5 (203 Reviews))Brand is an old entry in this market
      Old ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 300 MOQ
      Inknows 4% Lidocaine Maximum Strength Pain Relief Gel Patches with Auxiliary Patches for Neck Back Knee Joint Ache Muscle Soreness, 3.9” x 5.5”, 32-Count Box, NDC:83559-010-01
      Differentiation:
      Visible to the report owner only
      B0GWD7DMXC (4.3/5 (291 Reviews))Brand is a new entry in this market
      New ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 300 MOQ
    • What net profit margin are others making?

      Collapse
    • #Net Profit Margins: All vs New

      Visible to the report owner only

      Profitability difficulty
      Visible to the report owner only
      Visible to the report owner only
    • #Top Products by Net Profit Margin

      Visible to the report owner only

      Visible to the report owner only
      Visible to the report owner only
    • Is this a good time to enter the market?

      Collapse
    • #New Product Success Rates

      Visible to the report owner only

      New products success rate.

      What is the ratio of profitable products

      Profitable (Unidentifiable released date)
      Profitable (Old product)
      Profitable (New product)
      Profitable (New product on old listing)
      New products but non profitable
      No data available

      Nonprofitable new products divide by brands

      What is the ratio of different brands owning all nonprofitable new products

      YOAPA
      Sumifun
      Other
    • #Success Rate by Entry Time

      Visible to the report owner only

      How many products released each year

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

      How many products released each month

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

    • #Net Profit Margins by Entry Time

      Visible to the report owner only
    • What factors contribute to success or failure?

      Collapse
    • #Case Study

      Visible to the report owner only

      Success Cases
    What is Keble?

    Keble is an e-commerce AI Agent that helps sellers solve daily e-commerce issues. This report is generated by Keble AI.

    Analyze Product Opportunity with Keble
    1. One report to tell you whether to enter the market or not, significantly reducing inventory risk.
    Keble AI Agent